Search
Powered By HealthLine
Health Tools
 Chemotherapy: Eating Adivce
 Chemotherapy Myths
 Chemotherapy Guide
 Stages of Chemotherapy
 Post-Chemo Accessories
Featured Conditions
 Diet & Exercise
 Breast Cancer
 Skin Cancer
 Prostate
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Older Colon Cancer Patients Less Likely to Get Chemo

Study found one in two went without, while 87% of younger patients got it after surgery

By Alan Mozes
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Alzheimer's Disease
Basal Cell Carcinoma
Bladder Cancer
More...

Related Healthscout Videos
 border=
Going Under the Needle: Cancer Pain
Pocket-Sized Heart Help
Cracking the Code: Pompe Disease
Early Detection of Pancreatic Cancer: Medicine's Next Big Thing?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Coumadin
Detrol LA
Ditropan XL
More...

Related News Articles
 border=
Scientists Link 13 New Gene Regions to Heart Disease Risk
Early Rehab May Help Speed Recovery After Knee Surgery
Irregular Heart Beat Plus Stroke May Increase Dementia Risk
Surviving Serious Childhood Illness Takes Toll Later: Study
More...

TUESDAY, March 16 (HealthDay News) -- Older colon cancer patients are less likely than younger ones to receive potentially life-prolonging chemotherapy following surgery for their illness, a new study reveals.

The research indicates that those with advanced colon cancer who are over the age of 75 are both less likely to receive chemotherapy and more likely to receive less chemotherapy even when they are given the treatment.

Text Continues Below



Yet, prior research has indicated that surgery coupled with postoperative chemotherapy appears to reduce the risk of dying from the disease or experiencing a recurrence.

"So, we have to wonder why one of two older patients are not getting chemotherapy when the trials say they benefit from it," said study author Dr. Katherine L. Kahn, a professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).

"One reason is that there aren't that many older patients enrolled in study trials, and so doctors aren't comfortable with the research findings regarding the elderly," Kahn noted. "And there also isn't much written about how you manage those patients. But we studied what happens, and we find that the half that gets treated do great, just as well as younger patients who get chemotherapy."

Kahn, who is also a member of UCLA's Jonsson Comprehensive Cancer Center, and colleagues report their findings in the March 17 issue of the Journal of the American Medical Association.

According to American Cancer Society estimates, more than 106,000 Americans were newly diagnosed with colon cancer, and nearly 50,000 men and women died from the disease, last year alone.

Previous research has indicated that, regardless of age, patients who receive chemotherapy following surgery are 24 percent less likely to die and 32 percent less likely to experience the return of their cancer.

Page:  1 | 2 | 3 | Next >>

Copyright © 2010 HealthDay. All rights reserved.
Last updated 3/16/2010

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates




SOURCES: Katherine L. Kahn, M.D., professor, medicine, division of general internal medicine and health services research, department of medicine, David Geffen School of Medicine, University of California, Los Angeles, and senior natural scientist, Rand Corp., Santa Monica, Calif.; Frank A. Sinicrope, M.D., professor, medicine and oncology, Mayo Clinic, Rochester, Minn.; March 17, 2010, Journal of the American Medical Association


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire